Data / Form D filings / MetaVia Inc.
MetaVia Inc.: Form D filings
MetaVia Inc., a biotechnology company in Cambridge, MA, filed 13 Form D notices with the SEC between 2015 and 2025. The latest, on May 15, 2025, reports $10 million sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 545 CONCORD AVENUE, SUITE 210, Cambridge, MA, 02138
- Phone
- (857) 702-9600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1638287
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | New notice | $10,000,000 | $10,000,000 | 2 | May 8, 2025 | sec.gov | |
| Jul 1, 2024 | New notice | $16,998,224 | $16,998,224 | 2 | Jun 23, 2024 | sec.gov | |
| Oct 18, 2021 | New notice | $14,000,002 | $14,000,002 | 12 | Oct 1, 2021 | sec.gov | |
| Feb 1, 2021 | New notice | $10,000,000 | $10,000,000 | 10 | Jan 21, 2021 | sec.gov | |
| Jan 12, 2021 | New notice | $17,030,344 | $17,030,344 | 34 | Dec 31, 2020 | sec.gov | |
| Mar 30, 2017 | New notice | $12,540,704 | $12,540,704 | 26 | Mar 15, 2017 | sec.gov | |
| Apr 27, 2016 | Amendment | $14,000,000 | $10,601,500 | $3,398,500 | 59 | Jul 31, 2015 | sec.gov |
| Mar 10, 2016 | Amendment | $9,000,000 | $5,601,500 | $3,398,500 | 53 | Jul 31, 2015 | sec.gov |
| Dec 22, 2015 | Amendment | $5,451,000 | $5,451,000 | 52 | Jul 31, 2015 | sec.gov | |
| Aug 7, 2015 | Amendment | $2,801,000 | $2,801,000 | 36 | Jul 31, 2015 | sec.gov | |
| Aug 7, 2015 | New notice | $3,000,000 | $2,801,000 | $199,000 | 36 | Jul 31, 2015 | sec.gov |
| Apr 15, 2015 | New notice | $5,000,000 | $5,000,000 | 46 | Mar 31, 2015 | sec.gov | |
| Apr 8, 2015 | New notice | $3,000,000 | $2,739,049 | $260,951 | 28 | Nov 1, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark A. Glickman | Director | |
| Andrew L. Koven | Director | |
| Jason L. Groves | Director | |
| Marshall H. Woodworth | Executive Officer | |
| D. Gordon Strickland | Director | |
| Michael L. Salsbury | Director | |
| James P. Tursi | Director | |
| Hyung Heon Kim | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 12, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MetaVia Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.